Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease

Clin Gastroenterol Hepatol. 2006 Jul;4(7):882-7. doi: 10.1016/j.cgh.2006.02.003. Epub 2006 Apr 19.

Abstract

Background and aims: Measuring Crohn's disease (CD) activity is useful in clinical trials as well as in clinical practice, but each available instrument to measure such activity has some limitations. C-reactive protein (CRP) is a sensitive marker for inflammation and tissue injury. The aims of the study were: to assess the diagnostic value of low level of CRP for predicting a low CD activity, and to calculate optimal CRP cutoff value for selecting patients with moderate or high CD activity.

Methods: One hundred fifty consecutive patients with active or nonactive CD were included in the study without any pre-selection criteria. CRP was measured, and CD activity was calculated by means of the van Hees index (VHI).

Results: The median VHI score was 154.4 (interquartile range, 126.0-193.4), and the median CRP was 19.1 mg/L (interquartile range, 6.1-50.1 mg/L; upper limit of normal [N], 4 mg/L). Forty-nine percent of our patients had CRP >20 mg/L. CRP was significantly correlated to VHI (P = .0001). The probability that VHI was <150 if CRP was below upper limit of normal was equal to 1 (confidence interval, 0.891-1.000). The diagnostic value for CRP predicting a VHI > or =150 was high; the area under the receiver operating characteristic curve was equal to 0.844 (confidence interval, 0.783-0.906; P = .0001) with an optimal cutoff value of 21.6 mg/L, about 5 x N.

Conclusions: CRP appears useful to evaluate CD activity, especially to predict inactive or low activity CD.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Biomarkers / blood
  • C-Reactive Protein / metabolism*
  • Crohn Disease / blood*
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy
  • Female
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Predictive Value of Tests
  • ROC Curve
  • Reproducibility of Results
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • C-Reactive Protein
  • Methylprednisolone